
Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services
Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services
Expansion establishes role it plays in the oncology sector, company suggests
Pauses per manufacturer due to label-printing problems occur just under six times a year, on average, report finds
New sterile production area at Italy facility aims to benefit biologics manufacturing, such as BSL vaccines
Company also plans to design a manufacturing site for future mRNA vaccines and therapeutics
Will use new facility in Belgium for commercial production of plasmid DNA
CDMO giant invests nearly $1 billion in Switzerland and New Hampshire sites
Renovation more than doubles size of Massachusetts facility
Company also says that drug substance manufacturing can double at its facilities
As India Covid cases continue to spike, biotech company will provide resources to help boost local manufacturing
Partnership will begin with tackling Friedreich’s ataxia, then extend to other gene transfer therapies
Intends to provide fill-and-finish services for up to 200 million doses
Leiden site will be the company's fifth such facility, and first in Europe
FDA launches investigation into last month’s dose contamination
Sanford, NC, facility will be its sixth globally
Madison, WI, site now contains five manufacturing suites
Upon completion of five-year project, the location will serve as Asian hub for dose manufacturing
Dedicate new high-speed vial filling line for production of Moderna's Covid-19 vaccine
Agreement will now include fill-finish services at San Diego facility
With construction of third production line finished, biotech company says it can manufacture two billion doses annually
Acquisition further develops KD Pharma’s CDMO capabilities
The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate
Expansion in response to growing industry demand for products to transport temperature-sensitive cell and gene therapies
Location will be purchased by WuXi Biologics, according to report
Puts packaging business on pace for 2 billion by end of year